A new technique from Stanford, Nvidia, and Together AI lets models learn during inference rather than relying on static ...
The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.